Equities

Dr Reddy's Laboratories Ltd

Dr Reddy's Laboratories Ltd

Actions
  • Price (EUR)13.30
  • Today's Change0.20 / 1.53%
  • Shares traded50.00
  • 1 Year change+9.02%
  • Beta--
Data delayed at least 15 minutes, as of Nov 25 2024 07:01 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments81,17061,63844,083
Total Receivables, Net83,20675,77071,815
Total Inventory66,35448,67050,884
Prepaid expenses1,9471,4521,138
Other current assets, total15,37219,41013,936
Total current assets248,049206,940181,856
Property, plant & equipment, net76,88666,46262,169
Goodwill, net4,2534,2454,418
Intangibles, net36,95130,84927,246
Long term investments5,2555,3627,986
Note receivable - long term3,718054
Other long term assets1,632800894
Total assets387,518321,854292,827
LIABILITIES
Accounts payable21,54717,85715,971
Accrued expenses31,72829,31825,717
Notes payable/short-term debt12,7237,39027,082
Current portion long-term debt/capital leases1,3074,8041,017
Other current liabilities, total28,73426,47624,228
Total current liabilities96,03985,84594,015
Total long term debt5,9901,2785,746
Total debt20,02013,47233,845
Deferred income tax90983360
Minority interest------
Other liabilities, total4,0302,9072,479
Total liabilities106,96890,863102,300
SHAREHOLDERS EQUITY
Common stock834833832
Additional paid-in capital10,7659,6889,280
Retained earnings (accumulated deficit)267,591218,684178,572
Treasury stock - common(991)(1269)(1601)
Unrealized gain (loss)(2452)(2425)(1701)
Other equity, total4,8035,4805,145
Total equity280,550230,991190,527
Total liabilities & shareholders' equity387,518321,854292,827
Total common shares outstanding833831830
Treasury shares - common primary issue1.451.862.34
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.